Literature DB >> 21806649

The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life.

T H Taft1, E Kern, M A Kwiatek, I Hirano, N Gonsalves, L Keefer.   

Abstract

BACKGROUND: Eosinophilic oesophagitis (EoO) is a chronic disease characterised by significant symptoms and challenging treatment regimens. Health-related quality of life (HRQOL) is a useful way to direct patient care. EoO symptoms and treatment may impact patient HRQOL. Currently, there is no reliable and valid measure of adult EoO patient HRQOL. AIM: To validate the Adult Eosinophilic Oesophagitis Quality of Life (EoO-QOL-A) questionnaire as a measure of HRQOL in this population.
METHODS: The EoO patients aged 18-70 recruited via an out-patient GI clinic and two EoO advocacy groups completed the preliminary EoO-QOL-A, demographic and clinical information, and measures of general HRQOL, psychological distress and EoO symptom severity. A subset of patients completed test-retest assessments. Scale reliability, internal consistency, factor structure, concurrent and convergent validity were evaluated.
RESULTS: A total of 201 patients have participated. The study sample was primarily Caucasian, college-educated, and evenly split by gender. The average duration of disease was 7 years with duration of symptoms of 26 months prior to diagnosis. Patients reported were using both pharmacological and dietary treatments. Factor analysis yielded a 37-item, 5-factor structure: Eating/Diet Impact, Social Impact, Emotional Impact, Disease Anxiety and Choking Anxiety. The EoO-QOL-A demonstrated excellent internal consistency, split-half and test-retest reliability. Concurrent and convergent validity were supported by moderate correlations with established HRQOL measures, psychological distress and oesophageal symptoms.
CONCLUSIONS: The EoO-QOL-A is a valid and reliable disease-specific HRQOL measure for adult EoO patients. Developing the Adult Eosinophilic Oesophagitis Quality of Life is an important step in guiding treatment practices, improving disease education and standardising research protocols.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21806649     DOI: 10.1111/j.1365-2036.2011.04791.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  43 in total

Review 1.  Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches.

Authors:  Bharati Kochar; Evan S Dellon
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2015-09-12       Impact factor: 3.869

2.  Preliminary evaluation of maternal caregiver stress in pediatric eosinophilic gastrointestinal disorders.

Authors:  Tiffany H Taft; Sarah Ballou; Laurie Keefer
Journal:  J Pediatr Psychol       Date:  2012-01-23

3.  Evaluating the reliability and construct validity of the Eckardt symptom score as a measure of achalasia severity.

Authors:  T H Taft; D A Carlson; J Triggs; J Craft; K Starkey; R Yadlapati; D Gregory; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2018-01-08       Impact factor: 3.598

4.  Dysphagia and health-related quality of life in patients with eosinophilic esophagitis: a long-term follow-up.

Authors:  Helen Larsson; Karin Bergman; Caterina Finizia; Leif Johansson; Mogens Bove; Henrik Bergquist
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-08       Impact factor: 2.503

Review 5.  A Conceptual Approach to Understanding Treatment Response in Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Sandeep K Gupta
Journal:  Clin Gastroenterol Hepatol       Date:  2019-01-30       Impact factor: 11.382

Review 6.  White Paper AGA: Drug Development for Eosinophilic Esophagitis.

Authors:  Ikuo Hirano; Stuart Spechler; Glenn Furuta; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-22       Impact factor: 11.382

7.  Stigma perceptions in patients with eosinophilic gastrointestinal disorders.

Authors:  L Guadagnoli; T H Taft; L Keefer
Journal:  Dis Esophagus       Date:  2017-07-01       Impact factor: 3.429

8.  Eosinophilic esophagitis: historical perspective on an evolving disease.

Authors:  Stephen E Attwood; Glenn T Furuta
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

9.  Current hurdles in the management of eosinophilic oesophagitis: the next steps.

Authors:  Stephen Ea Attwood; Michael Sj Wilson
Journal:  World J Gastroenterol       Date:  2013-02-14       Impact factor: 5.742

10.  Cost Utility Analysis of Topical Steroids Compared With Dietary Elimination for Treatment of Eosinophilic Esophagitis.

Authors:  Cary C Cotton; Daniel Erim; Swathi Eluri; Sarah H Palmer; Daniel J Green; W Asher Wolf; Thomas M Runge; Stephanie Wheeler; Nicholas J Shaheen; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-07       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.